1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Structural Heart Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Structural Heart Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Structural Heart Market Regional Analysis
6.2 North America Structural Heart Market Revenue 2020-2028 (US$ Million)
6.3 North America Structural Heart Market Forecast Analysis
7. North America Structural Heart Market Analysis – by Product
7.1 Occluders
- 7.1.1 Overview
- 7.1.2 Occluders: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Annuloplasty Rings
- 7.2.1 Overview
- 7.2.2 Annuloplasty Rings: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Heart Valve Balloons
- 7.3.1 Overview
- 7.3.2 Heart Valve Balloons: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Structural Heart Market Analysis – by Procedure
8.1 Heart Valve Stenosis
- 8.1.1 Overview
- 8.1.2 Heart Valve Stenosis: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Heart Valve Regurgitation
- 8.2.1 Overview
- 8.2.2 Heart Valve Regurgitation: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Left Atrial Appendage Closure
- 8.3.1 Overview
- 8.3.2 Left Atrial Appendage Closure: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Structural Heart Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Ambulatory Surgical Centers
- 9.2.1 Overview
- 9.2.2 Ambulatory Surgical Centers: North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Cardiac Centers
- 9.3.1 Overview
- 9.3.2 Cardiac Centers : North America Structural Heart Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Structural Heart Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Structural Heart Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 North America Structural Heart Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Structural Heart Market Breakdown, by Product
- 10.2.1.1.2 US: North America Structural Heart Market Breakdown, by Procedure
- 10.2.1.1.3 US: North America Structural Heart Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Structural Heart Market Breakdown, by Product
- 10.2.1.2.2 Canada: North America Structural Heart Market Breakdown, by Procedure
- 10.2.1.2.3 Canada: North America Structural Heart Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Structural Heart Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Structural Heart Market Breakdown, by Product
- 10.2.1.3.2 Mexico : North America Structural Heart Market Breakdown, by Procedure
- 10.2.1.3.3 Mexico : North America Structural Heart Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Medtronic Plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Boston Scientific Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Artivion Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Edwards Lifesciences Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lepu Medical Technology Beijing Co Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Braile Biomedica Industry, Commerce and Representations Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Micro Interventional Devices Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations